Multi-target regulatory effects of rhaponticin in a rat model of hepatic fibrosis revealed by non-targeted metabolomics

Multi-target regulatory effects of rhaponticin in a rat model of hepatic fibrosis revealed by non-targeted metabolomics

IntroductionHepatic fibrosis (HF), a progressive chronic liver disease, is a serious threat to global public health. The lack of preventive and therapeutic strategies has created an urgent need for effective anti-fibrosis agents. There is growing evidence that natural products might provide safe and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Min Yang, Dihua Jiang, Longfei Huang, Tao Zhang, Wenfen Guo, Wenyan Lin, Jiali Zhao, Yunsheng Wei, Lang Peng, Yong-Jia Hao, Ying Zhou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	hepatic fibrosis traditional Chinese medicine rhaponticin metabolomic molecular mechanism
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1505309/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Metabolomics reveal the mechanism for anti-renal fibrosis effects of an n-butanol extract from Amygdalus mongolica
by: Gao Chen, et al.
Published: (2022-09-01)

Combined metabolomics and 16S rDNA sequence analyses of the gut microbiome reveal the action mechanism of Fructus Akebiae against hepatic fibrosis
by: Rong-Rong Wu, et al.
Published: (2025-02-01)

Integrated serum metabolomics and network pharmacology reveal molecular mechanism of Qixue Huazheng formula on peritoneal fibrosis
by: Xiaohui Meng, et al.
Published: (2025-01-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B
by: Ye Ji Jun, et al.
Published: (2024-11-01)

Transcriptomic and metabolomic analyses reveal the spatial role of carnitine metabolism in the progression of hepatitis B virus cirrhosis to hepatocellular carcinoma
by: Pengxiang Gao, et al.
Published: (2024-12-01)

The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease
by: Muhammad Abdel-Gawad, et al.
Published: (2023-10-01)

Metabolomic profiling of saliva from cystic fibrosis patients
by: M. Caterino, et al.
Published: (2025-01-01)

Amygdalin isolated from Amygdalus mongolica protects against hepatic fibrosis in rats
by: Wang Jia, et al.
Published: (2021-09-01)

Hepatic injury and metabolic perturbations in mice exposed to perfluorodecanoic acid revealed by metabolomics and lipidomics
by: Lvyun Sun, et al.
Published: (2025-01-01)

Noninvasive diagnosis of significant liver fibrosis in patients with chronic hepatitis B using nomogram and machine learning models
by: Chuan Jiang, et al.
Published: (2025-01-01)

Long-Term Monitoring of Liver Fibrosis and Steatosis in Patients with Chronic Hepatitis C after Achieving a Sustained Virologic Response to Antiviral Therapy
by: K. R. Dudina, et al.
Published: (2023-02-01)

Pathological Microenvironment‐Remodeling Nanoparticles to Alleviate Liver Fibrosis: Reversing Hepatocytes‐Hepatic Stellate Cells Malignant Crosstalk
by: Ling‐Feng Zhang, et al.
Published: (2025-01-01)

Comparative evaluation of APRI and MELD scores in the prediction of complications of chronic hepatitis in patients infected with hepatitis B or C viruses in Lubumbashi, democratic republic of Congo
by: Arsène Kabamba-Tshikongo, et al.
Published: (2025-02-01)

Widely targeted metabolomics analysis reveals the dynamically changes in volatile metabolites during xiaoqu baijiu fermentation
by: Zhenbing Ma, et al.
Published: (2025-01-01)

Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients
by: Qiyao Wei, et al.
Published: (2025-02-01)

Association of exposure to multiple volatile organic compounds with ultrasound-defined hepatic steatosis and fibrosis in the adult US population: NHANES 2017–2020
by: Wentao Shao, et al.
Published: (2025-01-01)

Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies
by: Xingpeng Di, et al.
Published: (2025-01-01)

Targeted Plasma Bile Acid Metabolomic Analysis in Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Hepatitis
by: Yuta Hirata, et al.
Published: (2024-12-01)

Unveiling Prevalence, Risk Factors, and Outcomes of Hepatitis D Among Vulnerable Communities in Romania
by: Liana Gheorghe, et al.
Published: (2024-12-01)

Screening of soybean antifungal isoflavones based on targeted metabolomics analysis
by: Nishbah Mughal, et al.
Published: (2025-01-01)

Evaluation of liver fibrosis in HCV-infected patients using two-dimensional shear-wave elastography (2D-SWE) before and after antiviral treatment
by: Inglot Marcin, et al.
Published: (2024-12-01)

Effect of dual targeting procyanidins nanoparticles on metabolomics of lipopolysaccharide-stimulated inflammatory macrophages
by: Shanshan Tie, et al.
Published: (2023-11-01)

Age-Dependent Effects of Butyl Benzyl Phthalate Exposure on Lipid Metabolism and Hepatic Fibrosis in Mice
by: Min-Seo Park, et al.
Published: (2025-01-01)

Integration of transcriptome and metabolome reveals key regulatory defense pathways associated with high temperature stress in cucumber (Cucumis sativus L.)
by: Yong Yuan, et al.
Published: (2025-01-01)

Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathway
by: Guanqi Dai, et al.
Published: (2025-01-01)

Chronic hepatitis C course at elderly and therapeutic approach
by: M. V. Mayevskaya, et al.
Published: (2011-02-01)

Integrating proteomics and metabolomics to elucidate the regulatory mechanisms of pimpled egg production in chickens
by: Wenqiang Li, et al.
Published: (2025-02-01)

Integrated transcriptomic and metabolomic analyses reveal critical gene regulatory network in response to drought stress in Dendrobium nobile Lindl
by: Chaoyan Lv, et al.
Published: (2025-02-01)

Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post‐COVID‐19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis
by: Sara Gangi, et al.
Published: (2025-01-01)

Revisiting the Metabolism of Donepezil in Rats Using Non-Targeted Metabolomics and Molecular Networking
by: Eun-Ji Park, et al.
Published: (2025-01-01)

Natural products targeting ubiquitination to combat kidney fibrosis
by: Lianhua Li, et al.
Published: (2025-01-01)

Non-targeted metabolomics reveals fatty acid and associated pathways driving resistance to whitefly and tomato leafminer in wild tomato accessions
by: Sunil Kumaraswamy, et al.
Published: (2025-01-01)

Qizhu Rougan Granules suppress liver fibrosis by inhibiting the expression of the P2Y14 receptor on hepatic stellate cells
by: Yujing Tao, et al.
Published: (2025-01-01)

Spinal cord injury induces transient activation of hepatic stellate cells in rat liver
by: Inmaculada Fernandez-Canadas, et al.
Published: (2025-01-01)

Integrated Transcriptomic and Targeted Metabolomic Analysis Reveals the Key Genes Involved in Triterpenoid Biosynthesis of <i>Ganoderma lucidum</i>
by: Xiaolan Xu, et al.
Published: (2025-01-01)

AdipoRon mitigates liver fibrosis by suppressing serine/glycine biosynthesis through ATF4-dependent glutaminolysis
by: Xiangting Zhang, et al.
Published: (2025-01-01)

Non-targeted Metabolomic Analysis of Differences in the Composition of Different Rice Varieties for Baijiu Production
by: LIU Maoke, TIAN Xinhui, LIU Yao, TANG Yuming, QIN Jian, FENG Jun, LIU Chengyuan
Published: (2024-12-01)

SOX9: a key transcriptional regulator in organ fibrosis
by: Yishuo Li, et al.
Published: (2025-02-01)

Targeted microbiome metabolomics reveals flaxseed oil supplementation regulated the gut microbiota and farnesoid X receptor pathway in high-fat diet mice
by: Chen Yang, et al.
Published: (2023-11-01)